Literature DB >> 16077174

CRH-stimulation of cyclic adenosine 5'-monophosphate pathway is partially inhibited by the coexpression of CRH-R1 and CRH-R2alpha.

G Maya-Núñez1, C Castro-Fernández, J P Méndez.   

Abstract

Corticotropin-releasing hormone (CRH) is one of the major proteins responsible for brain stress regulation. Two well-known receptors have been described: type 1 and type 2alpha, both members of the receptor superfamily of G protein-coupled receptors (GPCR). We investigated receptor regulation when both CRH receptor subtypes are coexpressed in the same mammalian cell line. When both types of receptors are coexpressed, cAMP second messenger production is partially inhibited compared to when receptors are expressed separately. However, neither binding kinetics nor internalization rates are modified by coexpression of these receptors. To our knowledge this is the first demonstration of receptor interaction that results in the modification of CRH-mediated signal transduction pathway. Because CRH-R1 and CRH-R2alpha have overlapping mRNA expression patterns in the brain, these receptors may be coexpressed in neurons, suggesting that receptor interaction may play an important role in the effect evoked by CRH, contributing to the complexity of differential coupling of the CRH receptors in different endocrine and stress behavior responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16077174     DOI: 10.1385/endo:27:1:067

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  44 in total

1.  Postnatal development of regional binding of corticotropin-releasing factor and adenylate cyclase activity in the rat brain.

Authors:  C Pihoker; S T Cain; C B Nemeroff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1992-07       Impact factor: 5.067

2.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.

Authors:  S Y Hsu; A J Hsueh
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

4.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

5.  Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells.

Authors:  E A Nimchinsky; P R Hof; W G Janssen; J H Morrison; C Schmauss
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

6.  Identification of a corticotropin-releasing factor-binding protein in the plasma membrane of AtT-20 mouse pituitary tumor cells and its regulation by dexamethasone.

Authors:  B E Rosendale; D B Jarrett; A G Robinson
Journal:  Endocrinology       Date:  1987-06       Impact factor: 4.736

7.  Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.

Authors:  S AbdAlla; H Lother; A el Massiery; U Quitterer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

8.  Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.

Authors:  M Perrin; C Donaldson; R Chen; A Blount; T Berggren; L Bilezikjian; P Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary.

Authors:  E Potter; S Sutton; C Donaldson; R Chen; M Perrin; K Lewis; P E Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells.

Authors:  Frank M Dautzenberg; Eric Gutknecht; Ilse Van der Linden; J Alberto Olivares-Reyes; Franz Dürrenberger; Richard L Hauger
Journal:  Biochem Pharmacol       Date:  2004-11-01       Impact factor: 5.858

View more
  1 in total

1.  Soluble corticotropin-releasing hormone receptor 2alpha splice variant is efficiently translated but not trafficked for secretion.

Authors:  Ryan T Evans; Audrey F Seasholtz
Journal:  Endocrinology       Date:  2009-06-11       Impact factor: 4.736

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.